Application of Quality by Design Approach to the Pharmaceutical Development of Anticancer Crude Extracts of Crocus sativus Perianth

被引:4
|
作者
Mykhailenko, Olha [1 ]
Ivanauskas, Liudas [2 ]
Bezruk, Ivan [1 ]
Petrikaite, Vilma [3 ,4 ]
Georgiyants, Victoriya [1 ]
机构
[1] Natl Univ Pharm, Dept Pharmaceut Chem, UA-61168 Kharkiv, Ukraine
[2] Lithuanian Univ Hlth Sci, Dept Analyt & Toxicol Chem, LT-44307 Kaunas, Lithuania
[3] Lithuanian Univ Hlth Sci, Inst Cardiol, Lab Drug Targets Histopathol, LT-50162 Kaunas, Lithuania
[4] Vilnius Univ, Life Sci Ctr, Inst Biotechnol, LT-10257 Vilnius, Lithuania
关键词
Quality by Design; risk assessment; design of experiments; Herbal Chemical Marker Ranking System; failure mode and effect analysis; saffron; anticancer herbal drugs; BREAST-CANCER CELLS; EXERTS ANTITUMOR-ACTIVITY; IN-VITRO; CYCLE ARREST; LUNG CARCINOGENESIS; DOWN-REGULATION; FERULIC ACID; L; CONSTITUENTS; MECHANISM;
D O I
10.3390/scipharm90010019
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The application of the Quality by Design (QbD) concept to extracts obtained from Crocus sativus perianth with potential anticancer activity will ensure the safety, efficiency, and quality control of the entire technological process, as well as determine the critical factors affecting the quality of extracts. Potentially critical points of the production of the plant extracts, including the cultivation and processing of the plant materials, the extraction process, and the choice of solvents, were identified using the Ishikawa diagram and FMEA risk assessment methods as well as the corrective actions proposed. The Herbal Chemical Marker Ranking System (HerbMars) approach was used to justify the Q-markers choice of Crocus, which takes into account bioavailability, pharmacological activity, and the presence of the selected standard. An experimental design (DoE) was used to assess the influence of potentially critical factors on the efficiency of the compound extraction from raw materials with water or ethanol. The presence of 16 compounds in Crocus perianth was determined by HPLC and their quantitative assessment was established. Selected compounds (ferulic acid, mangiferin, crocin, rutin, isoquercitrin) can be used for the quality control of Crocus perianth. In addition, the stigmas from the Volyn region met the requirements of ISO 3632 for saffron as a spice (category I). The cytotoxic activity against melanoma (IGR39) and triple-negative breast cancer (MDA-MB-231) cell lines of the hydroethanolic extract of C. sativus perianth was significantly more pronounced than the water extract, probably due to the chemical composition of the constituent components. The results show that the QbD approach is a powerful tool for process development for the production of quality herbal drugs.
引用
收藏
页数:23
相关论文
共 50 条
  • [31] Application of Quality Risk Assessment and DoE-Based Enhanced Analytical Quality by Design Approach to Development of Chromatography Method for Estimation of Combined Pharmaceutical Dosage Form of Five Drugs
    Prajapati, Pintu B.
    Jayswal, Kajal
    Shah, Shailesh A.
    JOURNAL OF CHROMATOGRAPHIC SCIENCE, 2021, 59 (08) : 714 - 729
  • [32] Application of Multivariate Tools in Pharmaceutical Product Development to Bridge Risk Assessment to Continuous Verification in a Quality by Design Environment
    Zomer, Simeone
    Gupta, Manish
    Scott, Andy
    JOURNAL OF PHARMACEUTICAL INNOVATION, 2010, 5 (03) : 109 - 118
  • [33] Application of Multivariate Tools in Pharmaceutical Product Development to Bridge Risk Assessment to Continuous Verification in a Quality by Design Environment
    Simeone Zomer
    Manish Gupta
    Andy Scott
    Journal of Pharmaceutical Innovation, 2010, 5 : 109 - 118
  • [34] Integrating tristimulus colorimetry into pharmaceutical development for color selection and physical appearance control: A quality-by-design approach
    Hetrick, Evan M.
    Vannoy, Jeffrey
    Montgomery, Laura L.
    Pack, Brian W.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 102 (08) : 2608 - 2621
  • [35] Design of a Pharmaceutical 3D Printer Using Quality-by-Design Approach
    Lafeber, I.
    de Boer, T. W. J.
    van Unen, W. H.
    Ouwerkerk, N.
    Guchelaar, H. J.
    Schimmel, K. J. M.
    JOURNAL OF PHARMACEUTICAL INNOVATION, 2024, 19 (06)
  • [36] Development of New Extracts of Crocus sativus L. By-Product from Two Different Italian Regions as New Potential Active Ingredient in Cosmetic Formulations
    Gigliobianco, Maria Rosa
    Cortese, Manuela
    Peregrina, Dolores Vargas
    Villa, Carla
    Lupidi, Giulio
    Pruccoli, Letizia
    Angeloni, Cristina
    Tarozzi, Andrea
    Censi, Roberta
    Di Martino, Piera
    COSMETICS, 2021, 8 (02)
  • [37] Application of Quality by Design Approach to Bioanalysis: Development of a Method for Elvitegravir Quantification in Human Plasma
    Baldelli, Sara
    Marrubini, Giorgio
    Cattaneo, Dario
    Clementi, Emilio
    Cerea, Matteo
    THERAPEUTIC DRUG MONITORING, 2017, 39 (05) : 531 - 542
  • [38] APPLICATIONS OF QUALITY IMPROVEMENT AND ROBUST DESIGN METHODS TO A PHARMACEUTICAL RESEARCH AND DEVELOPMENT
    Cho, Byung Rae
    Choi, Yongsun
    Shin, Sangmun
    INTERNATIONAL JOURNAL OF INDUSTRIAL ENGINEERING-THEORY APPLICATIONS AND PRACTICE, 2013, 20 (3-4): : 289 - U109
  • [39] Application of quality by design in the current drug development
    Zhang, Lan
    Mao, Shirui
    ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 12 (01) : 1 - 8
  • [40] Question-based review for pharmaceutical development: An enhanced quality approach
    Simoes, Ana
    Veiga, Francisco
    Vitorino, Carla
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2024, 195